QUOTE AND NEWS
Marketwire  Dec 1  Comment 
LONDON, ONTARIO and MILTON, ONTARIO -- (Marketwire) -- 12/01/11 -- Stellar Pharmaceuticals Inc. (OTCQB:SLXCF)(OTCBB:SLXCF)(PINK SHEETS:SLXCF) ("Stellar") and privately held Tribute Pharmaceuticals announced today that Stellar has acquired 100% of the
Marketwire  Nov 14  Comment 
LONDON, ONTARIO -- (Marketwire) -- 11/14/11 -- Stellar Pharmaceuticals Inc. (OTCQB:SLXCF)(OTCBB:SLXCF)(PINK SHEETS:SLXCF) ("Stellar" or "the Company"), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for
Marketwire  Sep 13  Comment 
LONDON, ONTARIO -- (Marketwire) -- 09/13/11 -- Stellar Pharmaceuticals Inc. (OTCQB: SLXCF)(OTCBB: SLXCF)(PINK SHEETS: SLXCF) ("Stellar" or "the Company"), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for
Marketwire  Aug 15  Comment 
LONDON, ONTARIO -- (Marketwire) -- 08/15/11 -- Stellar Pharmaceuticals Inc. (OTCQB: SLXCF) ("Stellar" or "the Company"), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today
Marketwire  Jan 18  Comment 
LONDON, ONTARIO -- (Marketwire) -- 01/18/11 -- Stellar Pharmaceuticals Inc. ("Stellar" or "the Company") (OTCBB: SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets,
Marketwire  Jan 6  Comment 
LONDON, ONTARIO -- (Marketwire) -- 01/06/11 -- Stellar Pharmaceuticals Inc. ("Stellar" or "the Company") (OTCBB: SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets,
Marketwire  Nov 10  Comment 
LONDON, ONTARIO -- (Marketwire) -- 11/10/10 -- Stellar Pharmaceuticals Inc. (OTCBB: SLXCF) ("Stellar" or "the Company"), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets,
Marketwire  Oct 11  Comment 
LONDON, ONTARIO -- (Marketwire) -- 10/11/10 -- Stellar Pharmaceuticals Inc. (OTCBB: SLXCF) (the "Company") is pleased to announce that the Company has completed a non-brokered private placement consisting of 1,000,000 units of the Company ("Units")
Marketwire  Oct 5  Comment 
LONDON, ONTARIO -- (Marketwire) -- 10/05/10 -- Stellar Pharmaceuticals Inc. (OTCBB: SLXCF) (the "Company") is pleased to announce that subject to regulatory acceptance, the Company is arranging a non-brokered private placement consisting of up to
Marketwire  Aug 11  Comment 
LONDON, ONTARIO -- (Marketwire) -- 08/11/10 -- Stellar Pharmaceuticals Inc. (OTCBB: SLXCF) ("Stellar" or "the Company"), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki